Gram-negative meningitis and infections in individuals treated with intrathecal baclofen for spasticity: A retrospective study

Developmental Medicine and Child Neurology

Volumn 48, Issue 6, 2006, Pages 450-455

  Wunderlich, Colleen A ^a,b   Krach, Linda E ^a  

^a GILLETTE CHILDREN'S SPECIALTY HEALTHCARE   (United States)

^b Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN A; CEFTRIAXONE; GENTAMICIN; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BLOOD CLOTTING DISORDER; CEREBRAL PALSY; CLINICAL ARTICLE; CLINICAL FEATURE; DEVICE INFECTION; DISEASE COURSE; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA; MALE; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; QUADRIPLEGIA; RETROSPECTIVE STUDY; SCHOOL CHILD; SPASTICITY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BACLOFEN; BACTERIAL INFECTIONS; CEREBRAL PALSY; CHILD; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; KLEBSIELLA; MALE; MENINGITIS, BACTERIAL; MUSCLE RELAXANTS, CENTRAL; PROTEUS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES;

EID: 33646698820     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1017/S0012162206000971     Document Type: Article

References (23)

1. Albright AL. (1996) Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 11 (Suppl. 1): 29-35.
2. Albright AL, Cervi A, Singletary J. (1991) Intrathecal baclofen for spasticity in cerebral palsy. JAMA 265: 1418-1422.
3. Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K. (1997) Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 87: 409-414.
4. Becker R, Alberti O, Bauer BL. (1997) Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol 244: 160-166.
5. Bhushan V, Paneth N, Kiely JL. (1993) Impact of improved survival of very low birthweight infants on recent secular trends in the prevalence of cerebral palsy. Pediatrics 91: 1094-1100.
6. Coffey RJ, Cahill D, Steers W, Park TS, Ordia J, Meythaler J, Herman R, Shetter AG, Levy R, Gill B, Smith R, Wilberger J, Loeser JD, Chabal C, Feler C, Robertson JT, Penn RD, Clarke A, Burchiel KJ, Liebrock LG. (1993) Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 78: 226-232.
7. Emery E. (2003) Baclofene intrathecal. Analyse de la litterature des resultats et complications. Neurochirurgie 49: 276-288. (In French)
8. Galloway A, Falope FZ. (2000) Pseudomonas aeruginosa infection in an intrathecal baclofen pump: Successful treatment with adjunct intra-reservoir gentamicin. Spinal Cord 38: 126-128.
9. Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML. (2003) Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg 39: 1-6.
10. Kamran S, Wright BD. (2001) Complications of intrathecal drug delivery systems. Neuromodulation 43: 111-115.
11. Matthews DJ, Wilson P. (1999) Cerebral Palsy. In: Molnar GE, Alexander MA, editors. Pediatric Rehabilitation. 3rd edn. Philadelphia, PA: Hanley and Belfus, Inc. p 193-213.
12. Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Hadley MN. (2001) Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy. Arch Phys Med Rehabil 82: 155-161.
13. Meythaler JM, McCary A, Hadley MN. (1997) Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: A preliminary report. J Neurosurg 87: 415-419.
14. Neidhardt FC. (1994) Bacterial structures. In: Ryan, KJ, editor. Sherris Medical Microbiology: An Introduction to Infectious Diseases. 3rd edn. Stamford, CT: Appleton & Lange. p 15-19.
15. Nelson KB, Ellenberg JH. (1982) Children who 'outgrew' cerebral palsy. Pediatrics 69: 529-536.
16. Ordia JI, Fischer E, Adamski E, Chagnon KG, Spatz EL. (2002) Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of cerebral origin. Neuromodulation 5: 16-24.
17. Palisano R, Rosenbaum P, Walter S, Wood E, Guluppi B. (1997) Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 39: 214-223.
18. Paneth V, Keily J. (1984) The frequency of cerebral palsy: A review of population studies in industrialized nations since 1950. In: Stanley F, Alberman E, editors. Epidemiology of the Cerebral Palsies. Clinics in Developmental Medicine No. 87. London: Mac Keith Press. p 46-56.
19. Penn RD, Kroin JS. (1987) Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg 66: 181-185.
20. Ray CG, Ryan KJ. (1994) Intravasular infection, bacteremia, and endotoxemia. In: Ryan, KJ, editor. Sherris Medical Microbiology: An Introduction to Infectious Diseases. 3rd edn. Stamford, CT: Appleton & Lange. p 798-799.
21. Schaeybroeck PV, Nuttin B, Lagae L, Schrijvers E. (2000) Intrathecal baclofen for intractable cerebral spasticity: A prospective placebo-controlled, double-blind study. Neurosurgery 46: 603-612.
22. Stempien L, Tsai T. (2000) Intrathecal baclofen pump use for spasticity: a clinical survey. Am J Phys Med Rehabil 79: 536-541.
23. Zed PJ, Stiver HG, Devenshire V, Jewesson PJ, Marra F. (2000) Continuous intrathecal pump infusion of baclofen with antibiotic drugs for treatment of pump-associated meningitis: Case Report. J Neurosurg 92: 347-349.